India Autoimmunity Diagnostics Market (2025-2030)
The India Autoimmunity Diagnostics Market was valued at $162.6 Million in 2025 and projected to reach to $285.9 Million by 2030, representing a compound annual growth rate of 9.9%. India's autoimmunity diagnostics market is positioned for substantial growth, expanding from USD 162.6 million in 2025 to USD 285.9 million by 2030.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
India Autoimmunity Diagnostics Market Trends and Insights
- This 9.9% compound annual growth rate reflects India's rising prevalence of autoimmune disorders, increasing healthcare awareness, and expanding diagnostic infrastructure across urban and semi-urban regions.
- India's growing middle class and improved access to advanced testing technologies are driving demand for early detection and management of conditions such as rheumatoid arthritis, lupus, and thyroid disorders. The Indian market benefits from a combination of demographic tailwinds and healthcare modernization.
- India's young population, coupled with lifestyle changes and environmental factors, has elevated autoimmune disease incidence, creating sustained demand for diagnostic solutions.
- Between 2025 and 2030, India is expected to see accelerated adoption of multiplex testing platforms, point-of-care diagnostics, and AI-enabled analysis tools.
- Government initiatives promoting preventive healthcare and laboratory standardization further support market expansion, positioning India as a high-growth hub within the Asia Pacific autoimmunity diagnostics landscape..
Key Market Statistics
- CAGR (2025-2030) 9.9% CAGR
- Market Size, 2025 ~USD 162.6 Million
- Forecast, 2030 ~USD 285.9 Million
- Country India
India Autoimmunity Diagnostics Market Overview
Rapid Market Expansion :
India's autoimmunity diagnostics market is growing at 9.9% CAGR, outpacing the global rate of 8.3%, driven by increasing disease prevalence and healthcare modernization across tier-1 and tier-2 cities.
Rising Disease Burden :
Growing prevalence of autoimmune disorders including rheumatoid arthritis, lupus, and thyroid disorders among India's population is fueling demand for advanced diagnostic solutions and early detection capabilities.
Healthcare Infrastructure Growth :
Expansion of diagnostic centers, pathology labs, and hospital networks in semi-urban regions is improving accessibility to autoimmunity testing, particularly in Tier-2 and Tier-3 cities across India.
Middle-Class Healthcare Spending :
India's expanding middle class demonstrates increasing willingness to invest in preventive healthcare and diagnostic testing, supporting market growth and adoption of advanced autoimmunity diagnostic technologies.
India Autoimmunity Diagnostics Market Dynamics
- This trajectory is supported by rising autoimmune disease incidence, enhanced healthcare awareness campaigns, and government initiatives promoting diagnostic accessibility.
- The market benefits from increasing laboratory automation and adoption of advanced testing methodologies across major metropolitan areas and emerging healthcare hubs. Key growth drivers include India's young, health-conscious population, rising disposable incomes, and growing private healthcare sector investments.
- Partnerships between diagnostic companies and healthcare providers are strengthening market penetration.
- However, challenges such as affordability in rural regions and regulatory compliance requirements present opportunities for localized solutions and cost-effective diagnostic innovations tailored to India's diverse healthcare landscape..
Related Ecosystem
Analytical And Scientific Instrumentation
- Environmental Testing
- Gas Chromatography
- Polymerase Chain Reaction (PCR)
- Automated Liquid Handling Systems
- Flow Cytometry
- Thermo Fisher Scientific Inc.
- Danaher Corporation
- Agilent Technologies, Inc.
- Merck KGaA
- Shimadzu Corporation
In Vitro Diagnostics
- Polymerase Chain Reaction (PCR)
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Dna Microarrays
- Assay Kits
- Microarrays
- ROCHE HOLDINGS AG
- Thermo Fisher Scientific Inc.
- Danaher Corporation
- Abbott Laboratories
- Biomerieux s.a.
Key Takeaways
- India's autoimmunity diagnostics market is valued at USD 162.6 million in 2025 and will reach USD 285.9 million by 2030, growing at a 9.9% CAGR.
- Rising autoimmune disease prevalence and improved healthcare access in India are primary drivers of diagnostic demand across urban and semi-urban populations.
- India is witnessing rapid adoption of advanced diagnostic technologies including multiplex assays, point-of-care testing, and AI-powered analysis platforms.
- Government healthcare initiatives and laboratory standardization policies in India are creating favorable conditions for market expansion and private sector investment.
Autoimmunity Diagnostics Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | AUTOANTIBODIES AND IMMUNOLOGIC TESTS (Test Type) |
| Forecast Period | 2025-2030 |
| Growth Rate | CAGR of 8.3% from 2025 to 2030 |
| Largest Segment | CONSUMABLES (Product) |
| Market Size Base Year (Billions) | ~USD 5.57 (2025) |
| Revenue Forecast (Billions) | ~USD 8.29 (2030) |
| Segments Covered | Product, Test Type, Disease Type, Type, End User |
India Autoimmunity Diagnostics Market Report Segmentation
5 segment dimensions are covered across the global market.
By Product
- Consumables
- Instruments
By Test Type
- Autoantibodies And Immunologic Tests
- Inflammatory Tests
- Other Tests
- Routine Laboratory Tests
- Urinalysis Tests
By Disease Type
- Organ-Specific Autoimmune Diseases
- Systemic Autoimmune Diseases
By Type
- Celiac Disease
- Inflammatory Bowel Disease
- Multiple Sclerosis
- Other Organ-Specific Autoimmune Diseases
- Other Systemic Autoimmune Diseases
- Psoriasis
- Rheumatoid Arthritis
- Systemic Lupus Erythematosus
- Type-1 Diabetes
By End User
- Clinical Laboratories
- Hospitals & Clinics
- Other End Users
INDIA: AUTOIMMUNITY DIAGNOSTICS MARKET, BY END USER, 2023–2031
| Segment | 2023 | 2024 | 2025 | 2026 | 2028 | 2029 | 2030 | 2031 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| CLINICAL LABORATORIES | 85.7 | 92 | 99.5 | 108.1 | 130 | 144.1 | 160.8 | 181.3 | 10.5 |
| HOSPITALS & CLINICS | 77.9 | 82.6 | 88.1 | 94.6 | 110.8 | 121.3 | 133.7 | 148.9 | 9.1 |
| OTHER END USERS | 32.9 | 34.5 | 36.4 | 38.6 | 44.3 | 47.9 | 52.3 | 57.6 | 7.9 |
| TOTAL | 196.5 | 209 | 224 | 241.4 | 285.1 | 313.3 | 346.8 | 387.8 | 9.6 |
Target Audience
- Diagnostic Equipment Manufacturers : Need India-specific market data to assess demand for autoimmunity testing equipment, identify distribution partnerships, and plan manufacturing or assembly operations in high-growth Indian markets.
- Healthcare Providers & Hospital Networks : Require market insights to justify investments in autoimmunity diagnostic capabilities, benchmark service offerings against competitors, and align service expansion with India's growing patient demand.
- Diagnostic Laboratory Chains : Seek India market analysis to guide expansion strategies, evaluate profitability of autoimmunity testing services, and identify geographic opportunities in underserved regions across the country.
- In Vitro Diagnostics (IVD) Companies : Need comprehensive India market data to support product development decisions, regulatory submissions, and commercial strategies for autoimmunity diagnostic assays and reagents.
- Healthcare Investors & Private Equity : Require validated market forecasts and growth drivers to evaluate investment opportunities in Indian diagnostic companies, healthcare infrastructure, and autoimmunity testing service providers.
Reasons to Buy this Report
- Market Size & Growth Validation : Obtain precise market valuation data for India (USD 162.6M in 2025) with verified 9.9% CAGR projections through 2030, enabling accurate business planning and investment decisions specific to the Indian market.
- Competitive Positioning Strategy : Understand India-specific market dynamics, regional healthcare infrastructure variations, and competitive landscape to develop targeted go-to-market strategies and identify untapped opportunities in tier-2 and tier-3 cities.
- Investment & Expansion Planning : Access detailed India market forecasts to support capital allocation decisions, facility expansion plans, and partnership strategies aligned with the country's 9.9% growth trajectory and healthcare modernization initiatives.
- Regulatory & Compliance Insights : Gain India-specific regulatory requirements, certification standards, and compliance frameworks essential for diagnostic product launches, ensuring market entry strategies align with local healthcare governance.
- Customer Segmentation & Targeting : Identify high-value customer segments within India including urban hospitals, diagnostic chains, and emerging semi-urban healthcare providers to optimize sales efforts and maximize market penetration.
Frequently asked questions
What is the current size of India's autoimmunity diagnostics market?
India's autoimmunity diagnostics market is valued at USD 162.6 million in 2025 and is projected to grow to USD 285.9 million by 2030.
What is the expected growth rate for India's autoimmunity diagnostics market?
India's autoimmunity diagnostics market is expected to grow at a compound annual growth rate (CAGR) of 9.9% from 2025 to 2030.
What factors are driving growth in India's autoimmunity diagnostics market?
Key drivers include rising prevalence of autoimmune diseases, increasing healthcare awareness, expanding diagnostic infrastructure, government healthcare initiatives, and growing adoption of advanced testing technologies in India.
Which autoimmune conditions are most commonly diagnosed in India?
In India, the most commonly diagnosed autoimmune conditions include rheumatoid arthritis, systemic lupus erythematosus, thyroid disorders, and other connective tissue diseases, driving demand for specialized diagnostics.
What diagnostic technologies are gaining adoption in India's market?
India is experiencing increased adoption of multiplex testing platforms, point-of-care diagnostics, immunoassay systems, and AI-enabled diagnostic analysis tools for autoimmune disease detection.
RESEARCH METHODOLOGY
The study involved estimating activities to determine the current size of the autoimmunity diagnostics market. Exhaustive secondary research was done to collect information on the autoimmunity diagnostics industry. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the autoimmunity diagnostics market.
Secondary Research
Various sources were utilized to gather information for this study in the secondary research process. These sources included company annual reports, press releases, and investor presentations; white papers; certified publications; articles by recognized authors; reputable websites; and information from regulatory bodies and databases, such as D&B Hoovers, Bloomberg Business, and Factiva.
Primary Research
In the primary research process, various sources from both the supply & demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources were mainly industry experts from the core and related industries and preferred suppliers, manufacturers, distributors, service providers, and organizations related to all segments of this industry’s value chain. In-depth interviews were conducted with primary respondents, including key industry participants, subject-matter experts, C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and assess prospects.
The following is a breakdown of the primary respondents:
Note 1: Others include sales, marketing, and product managers.
Note 2: Companies are classified into tiers based on their total revenues. As of 2024, Tier 1 = >USD 100 million, Tier 2 = USD 10 million to USD 100 million, and Tier 3 = < USD 10 million.
To know about the assumptions considered for the study, download the pdf brochure
| COMPANY NAME | DESIGNATION |
|---|---|
| Abbott Laboratories (US) | Product Specialist |
| Thermo Fisher Scientific Inc. (US) | Clinical Sales Specialist |
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the autoimmunity diagnostics market's total size. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
- The key players in the industry were identified through extensive secondary research.
- Primary and secondary research determined the revenues generated by leading players operating in the autoimmunity diagnostics market.
- All percentage shares, splits, and breakdowns were determined using secondary sources and verified through primary sources.
The research methodology used to estimate the market size includes the following:
Data Triangulation
The total market was split into several segments after arriving at the overall market size by applying the abovementioned process. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Market Definition
Autoimmune diseases are defined as a medical condition in which an individual's immune system produces antibodies that attack the body's normal tissues. autoimmunity diagnostics systematically identifies autoimmune disorders through clinical assessment and laboratory investigations to detect immune system dysfunction. This process typically involves routine laboratory testing, measurement of systemic inflammatory markers, detection of disease-specific autoantibodies, urinalysis, and other specialized immunologic assays.
Stakeholders
- Manufacturers & distributors of autoimmunity diagnostics products
- Clinical laboratories
- Hospitals
- Research institutes
- Government associations
- Venture capitalists & investors
Report Objectives
- To define, describe, segment, and forecast the global autoimmunity diagnostics market, by product, test type, disease type, end user, and region
- To provide detailed information regarding the major factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
- To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall autoimmunity diagnostics market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
- To forecast the size of the market segments with respect to five regions: North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
- To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
- To track and analyze company developments such as product launches & approvals, partnerships, acquisitions, agreements, and other developments
- To benchmark players within the market using the proprietary Company Evaluation Matrix framework, which analyzes market players on various parameters within the broad categories of business and product excellence
Get the Full Autoimmunity Diagnostics Market Report
Full forecast, segment splits, and company analysis for all Autoimmunity Diagnostics Market.
- US Autoimmunity Diagnostics Market
- Canada Autoimmunity Diagnostics Market
- UK Autoimmunity Diagnostics Market
- Germany Autoimmunity Diagnostics Market
- France Autoimmunity Diagnostics Market
- Italy Autoimmunity Diagnostics Market
- Spain Autoimmunity Diagnostics Market
- China Autoimmunity Diagnostics Market
- Japan Autoimmunity Diagnostics Market
- Australia Autoimmunity Diagnostics Market
- Rest Of Europe Autoimmunity Diagnostics Market
- Rest Of Asia Pacific Autoimmunity Diagnostics Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report
